Abstract
Throughout the development process of protein therapeutics a broad array of analytical techniques is applied on a routine basis to measure various molecular attributes. These measurements are carried out in the context of the quality control system of the product (routine monitoring of the product quality e.g. regarding stability during long-term storage) or as various characterization studies aimed at broadening the knowledge of the molecule. All stages of product development rely on analytical support: cell line and purification development, formulation development, compatibility studies, comparability exercises and also assessment of stability during production, storage and shipping.
The successful design of product control and characterization strategies to support biotherapeutic development requires intimate knowledge of protein analytical chemistry: the potential modifications that may occur in the protein molecule and the analytical techniques capable of measuring these modifications.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsFurther Reading
Arbogast LW, Brinson RG, Marino JP (2015) Mapping monoclonal antibody structure by 2D 13C NMR at natural abundance. Anal Chem 87(7):3556–3561
Berkowitz SA, Engen JR, Mazzeo JR, Jones GB (2012) Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars. Nat Rev Drug Discov 11(7):527–540
Butler JE (ed) (1991) Immunochemistry of solid-phase immunoassay. CRC Press, Boca Raton
Cavanagh J, Fairbrother WJ, Skelton NJ (2007) Protein NMR spectroscopy: principles and practice book, 2nd edn. Academic Press, San Diego
Chirino AJ, Mire-Sluis A (2004) Characterizing biological products and assessing comparability following manufacturing changes. Nat Biotechnol 22(11):1383–1391
Coligan J, Dunn B, Ploegh H, Speicher D, Wingfield P (eds) (1995) Current protocols in protein science. Wiley, New York
Crabb JW (ed) (1995) Techniques in protein chemistry VI. Academic, San Diego
Domon B, Aebersold R (2006) Mass spectrometry and protein analysis. Science 312(5771):212–217
Du Y, Walsh A, Ehrick R, Xu W, May K, Liu H (2012) Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies. MAbs 4(5):578–585
Dunbar BS (1994) Protein blotting: a practical approach. Oxford University Press, New York
Fekete S, Guillarme D, Sandra P, Sandra K (2016) Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals. Anal Chem 88(1):480–507
Folzer E, Diepold C, Bomans K, Finkler C, Schmidt R, Bulau P, Huwyler J, Mahler H-C, Koulov AV (2015) Selective oxidation of methionine and tryptophan residues in a therapeutic IgG1 molecule. J Pharm Sci 104:2824–2831
Gahoual R, Beck A, Leize-Wagner E, François YN (2016) Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products. J Chromatogr B Analyt Technol Biomed Life Sci 1032:61–78
Hames BD, Rickwood D (eds) (1990) Gel electrophoresis of proteins: a practical approach, 2nd edn. IRL Press, New York
Henderson R (2018) From electron crystallography to single particle Cryo EM (Nobel lecture). Angew Chem Int Ed Engl 57(34):10804–10825
Jiskoot W, Crommelin DJA (eds) (2005) Methods for structural analysis of protein pharmaceuticals. AAPS Press, Arlington
Kahle J, Wätzig H (2018) Determination of protein charge variants with (imaged) capillary isoelectric focusing and capillary zone electrophoresis. Electrophoresis 39(20):2492–2511
Kaltashov IA, Bobst CE, Abzalimov RR, Wang G, Baykal B, Wang S (2012) Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv 30(1):210–222
Liu H, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J (2008) Heterogeneity of monoclonal antibodies. J Pharm Sci 97(7):2426–2447
McEwen CN, Larsen BS (eds) (1998) Mass spectrometry of biological materials, 2nd edn. Dekker, New York
Moritz B, Schnaible V, Kiessig S, Heyne A, Wild M, Finkler C, Christians S, Mueller K, Zhang L, Furuya K, Hassel M, Hamm M, Rustandi R, He Y, Solano OS, Whitmore C, Park SA, Hansen D, Santos M, Lies M (2015) Evaluation of capillary zone electrophoresis for charge heterogeneity testing of monoclonal antibodies. J Chromatogr B Analyt Technol Biomed Life Sci 983-984:101–110
Müllertz A, Perrie Y, Rades T (eds) (2016) Analytical techniques in the pharmaceutical sciences. Springer, New York
Pace CN, Grimsley GR, Scholtz JM, Shaw KL (2014) Protein stability. In: eLS. Wiley, Chichester
Parr MK, Montacir O, Montacir H (2016) Physicochemical characterization of biopharmaceuticals. J Pharm Biomed Anal 130:366–389
Ponniah G, Nowak C, Neill A, Liu H (2017) Characterization of charge variants of a monoclonal antibody using weak anion exchange chromatography at subunit levels. Anal Biochem 520:49–57
Rathore D, Faustino A, Schiel J, Pang E, Boyne M, Rogstad S (2018) The role of mass spectrometry in the characterization of biologic protein products. Expert Rev Proteomics 15(5):431–449
Ríos Quiroz A, Lamerz J, Da Cunha T, Boillon A, Adler M, Finkler C, Huwyler J, Schmidt R, Mahler H-M, Koulov AV (2016) Factors governing the precision of subvisible particle measurement methods—a case study with a low-concentration therapeutic protein product in a prefilled syringe. Pharm Res 33:450–461
Salas-Solano O, Felten O (2008) Capillary electrophoresis methods for pharmaceutical analysis. Sep Sci Technol 9:401
Shirley BA (ed) (1995) Protein stability and folding. Humana Press, Totowa
Strege MA, Lagu AL (eds) (2004) Capillary electrophoresis of proteins and peptides. Humana Press, Totowa
Thorpe R, Wadhwa M, Mire-Sluis A (1997) The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology. Dev Biol Stand 91:79–88
Vlasak J, Ionescu R (2011) Fragmentation of monoclonal antibodies. MAbs 63:253–263
Vlasak J, Ionescu R (2008) Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods. Curr Pharm Biotechnol 9:468–481
Wei H, Mo J, Tao L, Russell RJ, Tymiak AA, Chen G, Iacob RE, Engen JR (2014) Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications. Drug Discov Today 19(1):95–102
Wild D (ed) (2013) The immunoassay handbook theory and applications of ligand binding, ELISA and related techniques, 4th edn. Elsevier, New York
Acknowledgements
This chapter is a re-work of part (including a number of figures) of the chapter “Biophysical and Biochemical Analysis of Recombinant Proteins”, by Tsutomu Arakawa and John Philo, which appeared in the previous editions of this book—cf. fourth edition, 2013. Despite the significant changes made to the original chapter, it still contains fragments of the excellent original text by Arakawa and Philo.
The author thanks Abbas Razvi and Marigone Lenjani for providing chromatograms and electropherograms shown in this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Koulov, A. (2019). Protein Stability and Characterization. In: Crommelin, D., Sindelar, R., Meibohm, B. (eds) Pharmaceutical Biotechnology. Springer, Cham. https://doi.org/10.1007/978-3-030-00710-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-00710-2_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-00709-6
Online ISBN: 978-3-030-00710-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)